Skip to main content
. 2015 Oct 8;6(38):41360–41369. doi: 10.18632/oncotarget.6023

Table 1. Characteristics of participants in the SBCSS, NBHS, and SCCS cohorts.

Study Characteristics Number 5-yr DFS/OS for NBHS and SCCS P-value
SBCSS No. of cases 463 79.3%
Age at diagnosis, median (range) 51.6 (26.1-74.3)
TNM stage <0.001
I 143 88.4%
IIA 165 84.2%
IIB 93 70.0%
III 46 51.9%
Unknown 16 80.4%
Grade 0.34
1 54 87.7%
2 148 79.3%
3 259 77.8%
Unknown 2 50.0%
Basal-like 0.03
Yes 217 75.4%
No 246 82.8%
NBHS No. of cases 86 89.2%
Age at diagnosis, median (range) 52.0 (28.0-75.0)
TNM stage 0.31
I 38 97.3%
IIA 6 80.0%
IIB 22 81.8%
III 5 100.0%
Unknown 15 78.6%
Grade 0.65
1-2 12 91.7%
3 68 89.3%
Unknown 6 83.3%
Basal-like 0.12
Yes 72 87.0%
No 14 100.0%
No. of deaths 11
SCCS No. of cases 47 82.5%
Age at diagnosis, median (range) 56.0 (44.0-74.0)
TNM stage <.0001
I 19 94.7%
IIA 6 100.0%
IIB 12 83.3%
III 5 40.0%
Unknown 5 60.0%
Grade 0.41
1-2 8 87.5%
3 29 78.4%
Unknown 10 90.0%
Basal-like 0.80
Yes 42 80.4%
No 5 100.0%